SCHEMBL3127933

SCHEMBL3127933

NC(=O)c1cc(F)ccc1C[CH]C(=O)N1CCC(OCc2ccccc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 4/20 0.44
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43
CARM1 Q86X55 3/20 0.39
PRMT6 Q96LA8 3/20 0.39
PRMT8 Q9NR22 2/20 0.39
PARP1 P09874 3/20 0.39
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
RPS6KB1 P23443 1/20 0.39
BTK Q06187 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3140703 0.82 PARP1 (0.43) PARP1BTK
SCHEMBL4096182 0.80 HTR2A (0.40) PARP1BTK
SCHEMBL5846478 0.78 BDKRB2 (0.41) BCHEPARP1BTK
SCHEMBL3140842 0.75 ALDH1A1 (0.35) PARP1BTK
SCHEMBL4086572 0.72 NPC1 (0.50) SMN1; SMN2KMT2A
SCHEMBL6163787 0.71 SMN1; SMN2 (0.45) BCHEGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7364619 0.71 BTK (0.37) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL23365208 0.70 CARM1 (0.58) BCHEGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL4080928 0.70 P2RX7 (0.40) PARP1SMN1; SMN2KMT2A
SCHEMBL4013732 0.70 CARM1 (0.54) BCHEGRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1636224-B1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSHORYLASE PROSIDION LTD (GB) 2010-07-14 EP disclosed
US-20090023703-A1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PROSIDION LIMITED (GB) 2009-01-22 US disclosed
US-7405210-B2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase OSI PHARMACEUTICALS, INC. (US) 2008-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023703-A1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PYGL, PYGM, PYGB BCHE 731/4885GRIN2D 2964/4885GRIN3B 3370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.